NCBI National Center for Biotechnology Information |
3UUO: The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia | ||||||||||||||||||||||||
* Click molecule labels to explore molecular sequence information.
|